Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Joined January 2023
- Tweets10
- Following5
- Followers26
- Likes0
Very excited to announce that we have closed a $33 Million seed round to advance a novel class of tRNA-based therapeutics for cancer.
Thank you to everyone involved in this important milestone, we look forward to advancing our lead compounds toward the clinic.
Read the full release here: globenewswire.com/news-relea…
#tRNA #Therapeutics #Oncology #Biotech #SeedFunding #CancerResearch #DrugDevelopment
Led by @4biocapital , the oversubscribed round includes strategic investment from three major pharma venture arms, AbbVie Ventures, Eli Lilly and Company, and Boehringer Ingelheim Venture Fund, as well as @DraperVC , @MissionBioCap and @AmericanCancer
Cloverleaf Bio retweeted
REVALIA BIO “HUMAN ORGAN RESEARCH” AWARD: 2023 @Yale Life Science Pitchfest
Wendy V. Gilbert (@WendyGScientist), PhD, Professor of Molecular Biophysics and Biochemistry
Project: Developing therapeutic tRNAs to revolutionize cancer therapy
Cloverleaf Bio retweeted
1/ Super grateful to be named to the @ForbesUnder30 Healthcare class of 2024! I'm thrilled to be listed alongside such incredible young innovators, scientists, and entrepreneurs.
forbes.com/30-under-30/2024/…
You can meet with us and the other participating startups on 10.11 during a Networking Mixer
with MassBio's innovation ecosystem. Register here: massbio.org/events/listing/m…
the-massbiodrive-f23-cohort/ (3/3)